Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Inside the Fight to Make a Revolutionary HIV Medication Widely Available

The controversial anti-HIV drug PrEP (or Truvada) is widely seen as a medicine for gay men. We speak to trans people, sex workers and black community leaders who believe that they need PrEP, too.

Published
22 September 2016
From
VICE
Why I believe everyone should have easy and affordable access to PrEP

Trans man Jamie Jaxon takes PrEP to prevent becoming HIV positive. Here he explains why NHS England should provide the treatment.

Published
21 September 2016
From
Gay Star News
CHMP Recommends for Approval Generic Version of Truvada

At its September meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Truvada – Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine/tenofovir disoproxil) for the treatment of HIV infection.

Published
20 September 2016
From
EATG
I wrote this piece while getting chemotherapy, because people have started using cancer patients like me as a weapon against gay people

Patient needs should never be pitted against each other and, as a cancer patient and gay man, I see the importance of both my chemotherapy and the need for PrEP as non-paralleled treatments that cannot be compared against each other.

Published
19 September 2016
From
The Independent
PrEP, test-and-treat offer most cost-effective methods for HIV prevention

Pre-exposure prophylaxis, or PrEP, and “test-and-treat” methods are both more cost-effective than the current strategy for the prevention of HIV transmission among men who have sex with men, according to researchers. The success of either strategy, however, depends on treatment initiation and adherence.

Published
19 September 2016
From
Healio
Bone loss and recovery in MSM aged 13-24 using PrEP for a year

Results from an open-label study in young people using PrEP showed that impact on bone health might be important is daily dosing is used for many years.

Published
19 September 2016
From
HIV i-Base
Lib Dems to vote on HIV blocking drug

The Liberal Democrats will call for drugs that block the contraction of HIV to be made available on the NHS.

Published
19 September 2016
From
The Independent
New York clinic outlines how to improve uptake of PrEP by transgender people

Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix of the Callen-Lorde

Published
19 September 2016
By
Roger Pebody
NHS funding cuts ‘forcing people to buy medicine through Facebook’

Patients and researchers say the medicine is safe, however pharmacists have warned that medicine bought online could be placebo pills or contain dangerous ingredients.

Published
16 September 2016
From
The Independent
NHS England warned against 'divide and rule' tactics over claims HIV drugs deprive cancer patients

Healthcare groups have warned NHS England not to pit patients against each other, after the body fuelled claims that HIV-preventing drugs would deprive cancer patients of treatment.

Published
16 September 2016
From
PinkNews
← First12345...95Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close